Aethlon Medical (NASDAQ:AEMD) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Aethlon Medical (NASDAQ:AEMD) in a report published on Sunday morning. The brokerage issued a sell rating on the medical equipment provider’s stock.

Separately, HC Wainwright reaffirmed a “buy” rating and set a $7.00 target price on shares of Aethlon Medical in a report on Friday, November 15th.

Aethlon Medical Price Performance

Aethlon Medical stock opened at $0.40 on Friday. Aethlon Medical has a 52 week low of $0.24 and a 52 week high of $2.35. The company has a market capitalization of $5.56 million, a price-to-earnings ratio of -0.14 and a beta of 1.74. The stock has a 50-day moving average price of $0.40 and a 200 day moving average price of $0.43.

Aethlon Medical Company Profile

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.